Cargando…

Developmental ablation of mature oligodendrocytes exacerbates adult CNS demyelination

Multiple sclerosis (MS) is a CNS neurodegenerative autoimmune disease characterized by loss of oligodendrocytes and myelin in the brain and the spinal cord that results in localized functional deficits. Several risk factors have been associated with MS, however none fully explain the enhanced suscep...

Descripción completa

Detalles Bibliográficos
Autores principales: Pajoohesh-Ganji, Ahdeah, Karl, Molly, Garrison, Eric, Osei-Bonsu, Nana Adwoa, Clarkson-Paredes, Cheryl, Ahn, Julie, Miller, Robert H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8474627/
https://www.ncbi.nlm.nih.gov/pubmed/34589870
http://dx.doi.org/10.1016/j.bbih.2020.100110
_version_ 1784575262027939840
author Pajoohesh-Ganji, Ahdeah
Karl, Molly
Garrison, Eric
Osei-Bonsu, Nana Adwoa
Clarkson-Paredes, Cheryl
Ahn, Julie
Miller, Robert H.
author_facet Pajoohesh-Ganji, Ahdeah
Karl, Molly
Garrison, Eric
Osei-Bonsu, Nana Adwoa
Clarkson-Paredes, Cheryl
Ahn, Julie
Miller, Robert H.
author_sort Pajoohesh-Ganji, Ahdeah
collection PubMed
description Multiple sclerosis (MS) is a CNS neurodegenerative autoimmune disease characterized by loss of oligodendrocytes and myelin in the brain and the spinal cord that results in localized functional deficits. Several risk factors have been associated with MS, however none fully explain the enhanced susceptibility seen in older individuals. Epidemiological data, based on geographical prevalence studies suggest that susceptibility is established early in life and frequently long before the diagnosis of disease raising the possibility that developmental events influence adult disease onset and progression. Here we test the hypothesis that selective loss of mature oligodendrocytes during postnatal development results in enhanced susceptibility to a demyelinating insult to the mature CNS. A transgenic mouse model was utilized to specifically induce apoptotic cell death in a subset of mature oligodendrocytes (MBP-iCP9) during the first 2 postnatal weeks followed by either a local LPC spinal cord injection or the induction of EAE in the adult animal. Immunostaining, immunoblotting, behavioral testing, and electron microscopy were utilized to examine the differences in the response between animals with developmental loss of oligodendrocytes and controls. We show that during development, oligodendrocyte apoptosis results in transient reductions in myelination and functional deficits that recover after 10–14 days. Compared to animals in which oligodendrocyte development was unperturbed, animals subjected to postnatal oligodendrocyte loss showed delayed recovery from an LPC lesion to the mature spinal cord. Unexpectedly, the induction and severity of MOG induced EAE was not significantly altered in animals following oligodendrocyte developmental loss even though there was a substantial increase in spinal cord tissue damage and CNS inflammation. It is unclear why the elevated glial responses seen in developmentally compromised animals were not reflected in enhanced functional deficits. These observations suggest that developmental loss of oligodendrocytes results in long lasting tissue changes that alter its response to subsequent insults and the capacity for repair in the adult.
format Online
Article
Text
id pubmed-8474627
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-84746272021-09-28 Developmental ablation of mature oligodendrocytes exacerbates adult CNS demyelination Pajoohesh-Ganji, Ahdeah Karl, Molly Garrison, Eric Osei-Bonsu, Nana Adwoa Clarkson-Paredes, Cheryl Ahn, Julie Miller, Robert H. Brain Behav Immun Health Full Length Article Multiple sclerosis (MS) is a CNS neurodegenerative autoimmune disease characterized by loss of oligodendrocytes and myelin in the brain and the spinal cord that results in localized functional deficits. Several risk factors have been associated with MS, however none fully explain the enhanced susceptibility seen in older individuals. Epidemiological data, based on geographical prevalence studies suggest that susceptibility is established early in life and frequently long before the diagnosis of disease raising the possibility that developmental events influence adult disease onset and progression. Here we test the hypothesis that selective loss of mature oligodendrocytes during postnatal development results in enhanced susceptibility to a demyelinating insult to the mature CNS. A transgenic mouse model was utilized to specifically induce apoptotic cell death in a subset of mature oligodendrocytes (MBP-iCP9) during the first 2 postnatal weeks followed by either a local LPC spinal cord injection or the induction of EAE in the adult animal. Immunostaining, immunoblotting, behavioral testing, and electron microscopy were utilized to examine the differences in the response between animals with developmental loss of oligodendrocytes and controls. We show that during development, oligodendrocyte apoptosis results in transient reductions in myelination and functional deficits that recover after 10–14 days. Compared to animals in which oligodendrocyte development was unperturbed, animals subjected to postnatal oligodendrocyte loss showed delayed recovery from an LPC lesion to the mature spinal cord. Unexpectedly, the induction and severity of MOG induced EAE was not significantly altered in animals following oligodendrocyte developmental loss even though there was a substantial increase in spinal cord tissue damage and CNS inflammation. It is unclear why the elevated glial responses seen in developmentally compromised animals were not reflected in enhanced functional deficits. These observations suggest that developmental loss of oligodendrocytes results in long lasting tissue changes that alter its response to subsequent insults and the capacity for repair in the adult. Elsevier 2020-07-26 /pmc/articles/PMC8474627/ /pubmed/34589870 http://dx.doi.org/10.1016/j.bbih.2020.100110 Text en © 2020 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Full Length Article
Pajoohesh-Ganji, Ahdeah
Karl, Molly
Garrison, Eric
Osei-Bonsu, Nana Adwoa
Clarkson-Paredes, Cheryl
Ahn, Julie
Miller, Robert H.
Developmental ablation of mature oligodendrocytes exacerbates adult CNS demyelination
title Developmental ablation of mature oligodendrocytes exacerbates adult CNS demyelination
title_full Developmental ablation of mature oligodendrocytes exacerbates adult CNS demyelination
title_fullStr Developmental ablation of mature oligodendrocytes exacerbates adult CNS demyelination
title_full_unstemmed Developmental ablation of mature oligodendrocytes exacerbates adult CNS demyelination
title_short Developmental ablation of mature oligodendrocytes exacerbates adult CNS demyelination
title_sort developmental ablation of mature oligodendrocytes exacerbates adult cns demyelination
topic Full Length Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8474627/
https://www.ncbi.nlm.nih.gov/pubmed/34589870
http://dx.doi.org/10.1016/j.bbih.2020.100110
work_keys_str_mv AT pajooheshganjiahdeah developmentalablationofmatureoligodendrocytesexacerbatesadultcnsdemyelination
AT karlmolly developmentalablationofmatureoligodendrocytesexacerbatesadultcnsdemyelination
AT garrisoneric developmentalablationofmatureoligodendrocytesexacerbatesadultcnsdemyelination
AT oseibonsunanaadwoa developmentalablationofmatureoligodendrocytesexacerbatesadultcnsdemyelination
AT clarksonparedescheryl developmentalablationofmatureoligodendrocytesexacerbatesadultcnsdemyelination
AT ahnjulie developmentalablationofmatureoligodendrocytesexacerbatesadultcnsdemyelination
AT millerroberth developmentalablationofmatureoligodendrocytesexacerbatesadultcnsdemyelination